Comparative study of extended release albuterol sulfate and long-acting inhaled salmeterol xinafoate in the treatment of nocturnal asthma

This publication has 17 references indexed in Scilit:

• Treatment of Nocturnal Airway Obstruction Improves Daytime Cognitive Performance in Asthmatics
  American Journal of Respiratory and Critical Care Medicine, 1997
• Regular formoterol treatment in mild asthma. Effect on bronchial responsiveness during and after treatment.
  American Journal of Respiratory and Critical Care Medicine, 1995
• Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma
  Published by American Medical Association (AMA) ,1994
• A Comparison of Salmeterol with Albuterol in the Treatment of Mild-to-Moderate Asthma
  New England Journal of Medicine, 1992
• Salmeterol in nocturnal asthma: a double blind, placebo controlled trial of a long acting inhaled beta 2 agonist.
  BMJ, 1990
• Long-term, double-blind comparison of controlled-release albuterol versus sustained-release theophylline in adolescents and adults with asthma
  Journal of Allergy and Clinical Immunology, 1990
• Formoterol, a new long-acting selective β-adrenergic receptor agonist: Double-blind comparison with salbutamol and placebo in children with asthma
  Journal of Allergy and Clinical Immunology, 1989
• Epidemiology of nocturnal asthma
  Published by Elsevier ,1988
• The Effects of Oral Slow-Release Terbutaline on the Circadian Variation in Spirometry and Arterial Blood Gas Levels in Patients with Chronic Airflow Obstruction
  Chest, 1985
• Asthma: analysis of sudden deaths and ventilatory arrests in hospital.
  BMJ, 1977